AACR Statement on Proposition 29, The California Cancer Research Act
PHILADELPHIA — Tobacco use is the leading preventable cause of premature death in the United States. It causes no fewer than 18 different types of cancer and is responsible for nearly a third of all cancer deaths. Every conceivable method should be employed to combat this preventable epidemic, and that is why the American Association for Cancer Research strongly supports Proposition 29, The California Cancer Research Act.
We know that the best way to prevent people from dying from cancer is simply to prevent them from using tobacco in the first place, and by increasing the tobacco tax by $1 per pack on cigarettes, that is what Proposition 29 would help achieve. Evidence shows that increasing taxes on tobacco is one of the most effective ways to prevent youth smoking and help smokers to quit; for every 10 percent increase in the cost of cigarettes, it is estimated that there is a 7 percent decline in youth smoking and a 3 to 5 percent decline in overall cigarette consumption.
Even the most successful efforts in tobacco control, however, won’t prevent the onslaught of illness and death that will result from current tobacco use. The delay in the onset of disease caused by tobacco means that what is done — or not done — today will directly and dramatically impact public health for decades to come.
By investing 60 percent of proceeds from the tobacco tax into biomedical research, Proposition 29 is a forward-thinking plan that would spur scientific innovation and accelerate lifesaving discoveries to patients suffering from cancer and other smoking-related illnesses.
By supporting Proposition 29, The California Cancer Research Act, voters can make California a model for the rest of the country and help bring us closer to a tobacco-free world.
About the AACR
Founded in 1907, the American Association for Cancer Research (AACR) is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR’s membership includes 34,000 laboratory, translational and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 17,000 attendees. In addition, the AACR publishes seven peer-reviewed scientific journals and a magazine for cancer survivors, patients and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration and scientific oversight of individual and team science grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer.
For more information about the AACR, visit www.AACR.org.